This federal contract award, valued at $3,044.82, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 10,000 units of chorionic gonad, a medical product, with a final completion date of April 29, 2025. The contract is a Firm Fixed Price Delivery Order and is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award is a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 10,000 units of Chorionic Gonad, a medical product, with a ceiling value of $5,473.80. The contract is awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of July 7, 2025. The contract is a firm fixed price type and does not utilize any set-aside designation, indicating open competition. AmerisourceBergen Drug...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of 10,000 units of Chorionic Gonad, a medical product, with a ceiling value of $5,643.67. It is a firm fixed-price delivery order contract with a completion date of May 23, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a Firm Fixed Price Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract, with a ceiling value of $54,236.25, is for the procurement of 10,000 units of Chorionic Gonad, a type of medical supply. The contract has a period of performance through February 14, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a key...
This federal contract award, valued at $3,344.69, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 10,000 units of Chorionic Gonad, a medical product, with a completion date of January 16, 2024. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award, valued at $5,134.39, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 10,000 units of chorionic gonad, a medical product. The contract is not set-aside and is a firm fixed-price arrangement with an ultimate completion date of April 28, 2025. Amerisourcebergen Drug Corp also holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,852.50, is for the delivery of 10,000 units of Chorionic Gonad, a medical product. The contract has a fixed-price delivery order type and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company...
The federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, from the Defense Logistics Agency (DLA). The $1,199.06 firm fixed-price delivery order (SPE2DB22D1106|SPE2DB25FEGU5) is for the procurement of 10,000 units of CHORIONIC GONAD, with a completion date of April 9, 2025. This award is not associated with a set-aside designation. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 10,000 units of Chorionic Gonadotropin, a hormone medication, with a firm fixed price of $6,743.47 and a completion date of June 30, 2025. The contract is not set-aside and is competed openly. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,783.72 firm fixed-price delivery order is for the supply of Chorionic Gonad 10,000 Unit Vials, with a completion date of January 14, 2022. The contract is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc.,...